NHS to Fund Ruxolitinib for Vitiligo

NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/nhs-fund-ruxolitinib-vitiligo-2026a10005sg?src=rss

Author :

Publish date : 2026-02-24 13:38:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

NHS to Fund Ruxolitinib for Vitiligo

Fewer Newborns Receive Hepatitis B Vaccination

Ruxolitinib: Landmark vitiligo cream targets immune cells that disrupt pigmentation

Related Posts

Showering Protocol for Hemodialysis Patients Shows No Increased Infection Risk

Where Is the Off Ramp for Psychotropic Medications?

CDC Alerts Clinicians About Potential for Imported Hantavirus Cases

Here’s What’s Next for Hantavirus Cruise Passengers

Cosmetic Interventions Are Booming. Many Say Ethical Conversations Are Lagging.

New Drug Reduces Breast Density With Fewer Side Effects

Showering Protocol for Hemodialysis Patients Shows No Increased Infection Risk

Where Is the Off Ramp for Psychotropic Medications?

CDC Alerts Clinicians About Potential for Imported Hantavirus Cases

Here’s What’s Next for Hantavirus Cruise Passengers

Cosmetic Interventions Are Booming. Many Say Ethical Conversations Are Lagging.

New Drug Reduces Breast Density With Fewer Side Effects

A vast dam across the Bering Strait could stop the AMOC collapsing

FDA Wants Better Pregnancy Safety Data on Approved Drugs

Categories

Archives